ARTICLE

FindCenter AddIcon

Ketamine for Depression Still Too Expensive for Widespread Use

By Technology Networks — 2020

A paper authored by researchers from McLean Hospital has determined that esketamine, a nasal spray to treat severe depression, is currently too expensive for widespread use. The study compared the costs and benefits of esketamine, an antidepressant approved by the U.S. Food and Drug Administration (FDA) last year for use in treatment-resistant major depressive disorder.

Read on www.technologynetworks.com

FindCenter Post-Image

Exploring the Mental Health Stigma in Black Communities

The Black community is more inclined to say that mental illness is associated with shame and embarrassment. Individuals and families in the Black community are also more likely to hide the illness.

FindCenter AddIcon

EXPLORE TOPIC

Clinical Depression